Saad Usmani, MD, Assistant Professor of Medicine and Director of Developmental Therapeutics at the UAMS Myeloma Institute, wrote and is leading the first clinical trial for high risk multiple myeloma, which will be conducted through SWOG (Southwest Oncology Group) at multiple sites in the U.S.

Read more